Dopamine D2 R/DRD2: Products

DRD2 encodes the D2 subtype of the dopamine receptor that inhibits adenylyl cyclase activity. Alternative splicing of this G protein-coupled receptor results in two transcript variants encoding different isoforms.

"Dopamine D2 R/DRD2" has 31 results in Products.
Sort by:

(-)-Quinpirole hydrochloride 

Selective D2-like agonist

L-DOPA 

Dopamine precursor

(S)-(-)-Sulpiride 

Standard selective D2-like antagonist

Haloperidol hydrochloride 

Dopamine antagonist; displays some D2 selectivity

Pimozide 

D2-like antagonist; also high affinity 5-HT7 antagonist

L-741,626 

High affinity D2 antagonist

(+)-PD 128907 hydrochloride 

High affinity D3 agonist (D3 ≥ D2 > D4)

Raclopride 

Potent and selective D2 and D3 antagonist

Eticlopride hydrochloride 

D2 and D3 antagonist (D3 > D2)

(RS)-(±)-Sulpiride 

Standard selective D2-like antagonist

Bromocriptine mesylate 

D2-like agonist (D2>D3>D4)

Dihydroergotamine mesylate 

α partial agonist; also D2-like partial agonist and 5-HT antagonist

Cabergoline 

D2-like agonist (D2>D3>D4)

Sumanirole maleate 

Selective D2 agonist

CNV Dopamine 

Caged dopamine; photolysed by UV light

Quinelorane hydrochloride 

D2 and D3 agonist

Nemonapride 

Highly potent D2-like antagonist; also 5-HT1A agonist

Mirtazapine 

Potent 5-HT2 antagonist; also 5-HT3, H1 and α2 antagonist; antidepressant

Amisulpride 

Selective D2 and D3 antagonist; atypical antipsychotic

Thioridazine hydrochloride 

Dopamine receptor antagonist; antipsychotic

Ropinirole 

Selective D2-like agonist

Asenapine maleate 

Non-selective 5-HT, dopamine, adrenalin and histamine receptor antagonist; antipsychotic agent

Rotigotine hydrochloride 

D2 and D3 agonist

Olanzapine 

5-HT2A antagonist; also D2 antagonist; atypical antipsychotic

Quetiapine hemifumarate 

5-HT2 antagonist; also D2 antagonist; atypical antipsychotic

Aripiprazole 

High affinity D2 and 5-HT1A receptor partial agonist; also 5-HT2A antagonist

MLS 1547 

G protein-biased D2 partial agonist

CELT-426 

Potent and partially selective hD2 dopamine receptor fluorescent antagonist
Flow
page of 1